intends to adjust the upper limit of the repurchase price to not exceed 70 yuan per share.

Tianchen Medical issued an announcement to ensure the smooth implementation of the share repurchase plan, the company plans to adjust the upper limit of the repurchase price from no more than RMB 28.03 per share to no more than RMB 70.00 per share. Except for the adjustment of the upper limit of the repurchase share price, the other contents of this repurchase share plan remain unchanged.